Bimeda Inc. announced the formal renaming of acquired vaccine production, research and diagnostic company, Texas Vet Lab Inc. (TVL), as Bimeda Biologicals Inc.
Bimeda said both TVL and the VetBio Inc. divisions of the business will henceforth operate under the new Bimeda Biologicals Inc. legal name.
Bimeda chief commercial officer Dave Cunningham said, "The renaming of the organization represents the first phase of our branding strategy and the continued integration of the TVL business, which is designed to see the company reach its potential both in domestic and export markets. The new name, Bimeda Biologicals Inc., respects the core identity of the business while formally incorporating it into the Bimeda group of companies."
Bimeda acquired the Texas-based biologicals business in December 2019, marking an important step for the company into the area of preventative medicines. At the time, Bimeda noted the significant potential for sustainable long-term growth and made a commitment to substantial investments to drive growth for both the existing vaccine portfolio and new product offerings.